http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17364583

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 662
issn 1094-5539
issueIdentifier 4
pageRange 657-662
publicationName Pulmonary Pharmacology & Therapeutics
startingPage 657
bibliographicCitation Kharidia J, Fogarty CM, LaForce CF, Maier G, Hsu R, Dunnington KM, Curry L, Baumgartner RA, Hanrahan JP. A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 2008 Aug;21(4):657–62. doi: 10.1016/j.pupt.2008.03.003.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdbe2796c11b8656ab7457795d7906d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc1db9766e2debffef7e2fddbc12ff6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c5b1de1ffb992d4c60e82a37177e331
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d8162ecfab54f2880e02b6686f4af55
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39f7291072362b0fde8757cb67fff7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f74a47d1501b7c6dca191c07181733a5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e08c8708f9658df1d5b1760993aa02a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9da2fc2e793e8d8caf8e8cf69c46962
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6ca3bbafb1e1ab9876cc1f8eb2575e3
date 200808
identifier https://doi.org/10.1016/j.pupt.2008.03.003
https://pubmed.ncbi.nlm.nih.gov/18501650
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20717
https://portal.issn.org/resource/ISSN/1094-5539
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Kharidia J, Fogarty CM, Laforce CF, Maier G, Hsu R, Dunnington KM, Curry L, Baumgartner RA, Hanrahan JP: A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2008 Aug;21(4):657-62. doi: 10.1016/j.pupt.2008.03.003. Epub 2008 Apr 7.
discusses http://id.nlm.nih.gov/mesh/M0311929
http://id.nlm.nih.gov/mesh/M0007823
http://id.nlm.nih.gov/mesh/M0002975
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001993Q000008
http://id.nlm.nih.gov/mesh/D029424Q000188
http://id.nlm.nih.gov/mesh/D004983Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009330
http://id.nlm.nih.gov/mesh/D005541Q000187
http://id.nlm.nih.gov/mesh/D004983Q000493
http://id.nlm.nih.gov/mesh/D000068759
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D001993Q000493
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D000280
http://id.nlm.nih.gov/mesh/D013237
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D018592
http://id.nlm.nih.gov/mesh/D019540
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3083544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9827062
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10727

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46506392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136046712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID154

Total number of triples: 55.